Publicaciones en colaboración con investigadores/as de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (14)

2020

  1. An intact gut microbiome protects genetically predisposed mice against leukemia

    Blood, Vol. 136, Núm. 18, pp. 2003-2017

2019

  1. Dnmt1 links BCR-ABLp210 to epigenetic tumor stem cell priming in myeloid leukemia

    Leukemia, Vol. 33, Núm. 1, pp. 249-278

  2. Infectious stimuli promote malignant B-cell acute lymphoblastic leukemia in the absence of AID

    Nature Communications, Vol. 10, Núm. 1

2018

  1. Lmo2 expression defines tumor cell identity during T-cell leukemogenesis

    EMBO Journal, Vol. 37, Núm. 14

  2. Loss of Pax5 exploits sca1-BCR-ABLp190 susceptibility to confer the metabolic shift essential for pB-ALL

    Cancer Research, Vol. 78, Núm. 10, pp. 2669-2679

2017

  1. Infection exposure promotes ETV6-RUNX1 precursor B-cell leukemia via impaired H3K4 demethylases

    Cancer Research, Vol. 77, Núm. 16, pp. 4365-4377

2015

  1. Infection exposure is a causal factor in B-cell precursor acute lymphoblastic leukemia as a result of Pax5-inherited susceptibility

    Cancer Discovery, Vol. 5, Núm. 12, pp. 1328-1343

2013

  1. CD133+ cell content correlates with tumour growth in melanomas from skin with chronic sun-induced damage

    British Journal of Dermatology, Vol. 169, Núm. 4, pp. 830-837

2012

  1. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors

    EMBO Journal, Vol. 31, Núm. 18, pp. 3704-3717

2010

  1. Bcl2 is not required for the development and maintenance of leukemia stem cells in mice

    Carcinogenesis, Vol. 31, Núm. 7, pp. 1292-1297

2007

  1. Adipose tissue mass is modulated by SLUG (SNAI2)

    Human Molecular Genetics, Vol. 16, Núm. 23, pp. 2972-2986

  2. Sustained leukaemic phenotype after inactivation of BCR-ABLp190 in mice

    Oncogene, Vol. 26, Núm. 12, pp. 1702-1713

2006

  1. SLUG (SNAI2) overexpression in embryonic development

    Cytogenetic and Genome Research, Vol. 114, Núm. 1, pp. 24-29

2005

  1. Improving the development on new cancer treatments: Challenges and opportunities

    Drug Design Reviews Online, Vol. 2, Núm. 5, pp. 341-348